Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

430 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacy.
Grunewald L, Andersch L, Helmsauer K, Schwiebert S, Klaus A, Henssen AG, Straka T, Lodrini M, Wicha SG, Fuchs S, Hertwig F, Westermann F, Vitali A, Caramel C, Büchel G, Eilers M, Astrahantseff K, Eggert A, Höpken UE, Schulte JH, Blankenstein T, Anders K, Künkele A. Grunewald L, et al. Among authors: eggert a. Pharmacol Res. 2025 Jan 17;212:107608. doi: 10.1016/j.phrs.2025.107608. Online ahead of print. Pharmacol Res. 2025. PMID: 39828101 Free article.
Everolimus with or without Mycophenolate Mofetil for Graft-versus-Host Disease Prophylaxis after Hematopoietic Stem Cell Transplantation in Children with Acute Kidney Injury: A Single-Center Retrospective Analysis.
Zirngibl F, Gebert P, Materne B, Launspach M, Künkele A, Hundsdoerfer P, Cyrull S, Deubzer HE, Kühl JS, Eggert A, Lang P, Oevermann L, von Stackelberg A, Schulte JH. Zirngibl F, et al. Among authors: eggert a. Transplant Cell Ther. 2025 Jan 7:S2666-6367(25)00003-X. doi: 10.1016/j.jtct.2025.01.002. Online ahead of print. Transplant Cell Ther. 2025. PMID: 39788293 Free article.
Serially quantifying TERT rearrangement breakpoints in circulating tumor DNA enables minimal residual disease monitoring in patients with neuroblastoma.
Hollander JF, Szymansky A, Wünschel J, Astrahantseff K, Rosswog C, Thorwarth A, Thole-Kliesch TM, Chamorro Gonzalez R, Hundsdörfer P, Hauptmann K, Schmelz K, Gürgen D, Rogasch JMM, Henssen AG, Fischer M, Schulte JH, Eckert C, Eggert A, Lodrini M, Deubzer HE. Hollander JF, et al. Among authors: eggert a. Cancer Res Commun. 2025 Jan 6. doi: 10.1158/2767-9764.CRC-24-0569. Online ahead of print. Cancer Res Commun. 2025. PMID: 39760332 Free article.
Copy-number dosage regulates telomere maintenance and disease-associated pathways in neuroblastoma.
Burkert M, Blanc E, Thiessen N, Weber C, Toedling J, Monti R, Dombrowe VM, Stella de Biase M, Kaufmann TL, Haase K, Waszak SM, Eggert A, Beule D, Schulte JH, Ohler U, Schwarz RF. Burkert M, et al. Among authors: eggert a. iScience. 2024 Sep 10;27(10):110918. doi: 10.1016/j.isci.2024.110918. eCollection 2024 Oct 18. iScience. 2024. PMID: 39635126 Free PMC article.
The Other Site of Rhabdomyosarcoma.
Kern L, Henssen A, Eggert A, Scheer M. Kern L, et al. Among authors: eggert a. Cancer Med. 2024 Oct;13(20):e70348. doi: 10.1002/cam4.70348. Cancer Med. 2024. PMID: 39463067 Free PMC article.
Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis.
Sprüssel A, Suzuki T, Miyata N, Astrahantseff K, Szymansky A, Toedling J, Thole-Kliesch TM, Ballagee A, Lodrini M, Künkele A, Truss M, Heukamp LC, Mathia S, Hertwig F, Rosenberger C, Eggert A, Deubzer HE, Schulte JH. Sprüssel A, et al. Among authors: eggert a. J Clin Med. 2024 Oct 12;13(20):6081. doi: 10.3390/jcm13206081. J Clin Med. 2024. PMID: 39458030 Free PMC article.
430 results